To hear about similar clinical trials, please enter your email below
Trial Title:
A Non-interventional Study With Advanced Lung Squamous Cell Carcinoma
NCT ID:
NCT05984017
Condition:
Advanced Lung Squamous Cell Carcinoma
Conditions: Official terms:
Carcinoma
Carcinoma, Squamous Cell
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
No treatment is included in this study
Description:
No drug intervention or tissue sampling will be included in this study.
Summary:
This is a descriptive observational study, in which data are collected in an
epidemiological fashion and prospective. This study does not intend to intervene the
current medical practice of the recruited patients.
Criteria for eligibility:
Study pop:
advanced or metastatic (stage IV) lung squamous cell carcinoma
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patients must be ≥18 years.
- Provision of fully informed consent prior to any study specific procedures.
- Advanced or metastatic lung squamous cell carcinoma confirmed by histology or
cytology.
- According to the RECIST 1.1 standard, the patient must have at least one measurable
lesion.
Exclusion Criteria:
- None
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Yongchang Zhang
Address:
City:
Changsha
Zip:
410013
Country:
China
Status:
Recruiting
Contact:
Last name:
Yongchang Yongchang Zhang, MD
Phone:
+8613873123436
Phone ext:
+8613873123436
Email:
zhangyongchang@csu.edu.cn
Start date:
July 1, 2021
Completion date:
December 31, 2025
Lead sponsor:
Agency:
Hunan Province Tumor Hospital
Agency class:
Other
Source:
Hunan Province Tumor Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05984017
